Hmmmm...
"to import, sell and distribute a2 Platinum® IMF product (Stages 1 and 2) from New Zealand into the US has been
approved through to 6 January 2023."
Yet
"This product is not currently available in
inventory and needs to be manufactured as soon as possible. a2MC previously indicated to the FDA that if approval
was obtained by 30 September 2022, it had the capacity through Synlait Milk Limited (Synlait) to manufacture 9
million cans of a2 Platinum® (equivalent to 211 million 8oz bottles) by 30 June 2023 if required during the supply
shortage period subject to customer demand."
Ann: FDA approval to supply infant milk formula to United States, page-17
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.88 |
Change
0.000(0.00%) |
Mkt cap ! $4.973B | |||
| Open | High | Low | Value | Volume |
| $6.90 | $6.90 | $6.80 | $7.266M | 1.060M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12501 | $6.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.88 | 33092 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |